Iomeprol Injectable Solution Suppliers & Bulk Manufacturers
Available Forms: Injectable Solution
Available Strengths: 350 mg/mL and 400 mg/mL
Reference Brands: Iomeron(US & EU)
Category:
Contrast Agent
Iomeprol is a contrast agent that enhances tissue and vascular visibility during imaging by increasing radiopacity. It supports accurate diagnosis, improves visualization of blood vessels and organs, and facilitates precise imaging in angiography, CT scans, and diagnostic procedures. Benefits include high-quality imaging, safety, and rapid excretion, supporting effective healthcare worldwide.
Iomeprol Injectable Solution is available in Injectable Solution
and strengths such as 350 mg/mL and 400 mg/mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Iomeprol Injectable Solution is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Iomeprol Injectable Solution can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Iomeprol injectable solution, marketed as Iomeron, is approved in the US by the FDA and in the EU via EMA for contrast-enhanced imaging procedures including CT angiography and vascular imaging. Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality information to ensure safety and effectiveness, while the EMA ensures compliance with regional safety and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence supports timely approval, safe administration, and worldwide availability, supporting high-quality diagnostic imaging globally.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing